11/22
08:00 am
gpcr
Structure Therapeutics Inc. (GPCR): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts [Yahoo! Finance]
Medium
Report
Structure Therapeutics Inc. (GPCR): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts [Yahoo! Finance]
11/15
08:30 am
gpcr
Structure Therapeutics to Participate in the Jefferies London Healthcare Conference
High
Report
Structure Therapeutics to Participate in the Jefferies London Healthcare Conference
11/13
04:05 pm
gpcr
Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights
Medium
Report
Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights
11/13
04:02 pm
gpcr
Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity [Yahoo! Finance]
Medium
Report
Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity [Yahoo! Finance]
11/13
04:01 pm
gpcr
Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity
Medium
Report
Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity
10/31
08:30 am
gpcr
Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024
Medium
Report
Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024
10/22
02:09 pm
gpcr
Structure Therapeutics: Potential To Have Best-In-Class GLP-1 Agonist For Obesity Patients [Seeking Alpha]
Low
Report
Structure Therapeutics: Potential To Have Best-In-Class GLP-1 Agonist For Obesity Patients [Seeking Alpha]
9/23
08:53 am
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Medium
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
9/23
07:59 am
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $118.00 price target on the stock.
Medium
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $118.00 price target on the stock.
9/17
04:05 pm
gpcr
Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer
Low
Report
Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer
9/16
12:11 pm
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Low
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
9/9
12:14 pm
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Low
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
9/5
01:24 am
gpcr
Structure Therapeutics Inc. (GPCR): Among the Best Mid-Cap Healthcare Stocks To Buy Now [Yahoo! Finance]
Low
Report
Structure Therapeutics Inc. (GPCR): Among the Best Mid-Cap Healthcare Stocks To Buy Now [Yahoo! Finance]
8/27
04:05 pm
gpcr
Structure Therapeutics Appoints Angus C. Russell to Board of Directors
Medium
Report
Structure Therapeutics Appoints Angus C. Russell to Board of Directors
8/26
04:14 pm
gpcr
Structure Therapeutics Announces Participation in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Structure Therapeutics Announces Participation in Upcoming Investor Conferences [Yahoo! Finance]
8/26
04:05 pm
gpcr
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
Low
Report
Structure Therapeutics Announces Participation in Upcoming Investor Conferences